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1. INTRODUCTION 
The antibiotic rifampicin, a semi-synthetic de- 
rivative of rifamycin SV, inhibits bacterial RNA 
polymerase by forming a very stable complex with 
the enzyme in a 1: 1 ratio [ 11. In the search for rifa- 
mycins which would affect rifampicin-resistant 
bacteria, a large number of derivatives with bulky 
lipophilic side-chains were synthesized. Many of 
them proved capable of inhibiting the RNA poly- 
merase of rifampicin-resistant E.coli mutants [2] 
and a number of other enzymes responsible for the 
polymerization of nucleotides [3]. However, the 
mechanism of action of these compounds against 
rifampicin-resistant RNA polymerases is different 
from the mechanism whereby rifampicin acts on the 
normal RNA polymerase. For example, the best- 
studied of these rifamycin derivatives, AF/013, 
unlike rifampicin prevents the binding of RNA 
polymerase to DNA [2,4]. 
The first rifamycin derivatives inhibiting a rif- 
ampicin-resistant Escherichia coli RNA polymerase 
by a similar mechanism to the action of rifampicin 
on a sensitive RNA polymerase were found among 
the dimeric rifamycins [5]. We have synthesized a 
number of derivatives of rifamycin SV with various 
substitutions in the 3rd position of the naphtho- 
quinone nucleus; some of them proved capable of 
inhibiting rifampicin-resistant RNA polymerase of 
E.coli mutants. This paper describes a derivative of 
rifamycin SV, 3-(6-bromo-4-phenyl-2-hydrazono- 
methyl-quinazoline)-rifamycin SV (fig. 1) which 
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Fig. 1. 3-(6-bromo-4-phenyl-2-hydrazonomethyl-quina- 
zoline)-Rifamycin SV (RM41). 
inhibits a rifampicin-resistant RNA polymerase by 
a similar mechanism to that of the action of rifam- 
picin on a sensitive RNA polymerase. 
2. MATERIALS AND METHODS 
Purified RNA polymerase was obtained from 
rifampicin-resistant mutant E.coli K12 RpoB255 
and RpoB4 cells by the method in [6] as described 
[7]. RNA polymerase activity was assayed in 200 ~1 
reaction samples containing the buffer solution: 
0.01 M Tris (pH 80), 0.1 M NaCI, 0.01 M MgCl2. 
Phage T2 DNA (100 ,ug/ml) was used as the 
template. The order in which the samples were 
made up and incubated is specified in the figure 
legends. The binding of RNA polymerase to T2 
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DNA was assayed with the help of nitrocellulose 
filters as in (71. 3-(6-bromo-4-phenyl-2-hydrazono- 
methyl-quinazoline)-Rifamycin SV (the code name 
RM41) was synthesized by mixing equimolar 
amounts of 3-formyl rifamycin SV and 6-bromo- 
4-phenyl-2-hydrazonomethyl-quinazoline i  tetra- 
hydrofuran with subsequent solvent removal and 
recrystallization of the product from ethyl acetate. 
The product was analytically pure: silica gel 
chromatography in a chloroform-methanol (9 : 1) 
system showed one spot. Rifamycins were dissolv- 
ed in dimethylsulfoxide (10 mg/ml). 
3. RESULTS AND DISCUSSION 
Fig. 2 shows the effects of rifampicin and RM41 
on rifampicin-resistant and -sensitive RNA poly- 
merases. RM41 completely inhibits the rifampicin- 
resistant RNA polymerase, though this requires 
appreciably higher concentrations than the inhibi- 
tion of the sensitive RNA polymerase. It is inter- 
esting that, although RM41 is much more effective 
than rifampicin in inhibiting the rifampicin-resis- 
tant mutant RNA polymerase, the action of RM41 
on the rifampicin-sensitive RNA polymerase is less 
effective than that of rifampicin (fig. 2). RM41 
does not seem to penetrate into intact E.coli cells, 
for it does not affect their reproduction. 
To elucidate the mechanism of action of RM41 
on the resistant RNA polymerase, we studied its 
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Fig. 2. Effects of rifampicin and RM41 on rifampicin- 
resistant (A) and sensitive (B) RNA polymerases. The 
reaction mixture was made up in the following order: 
buffer solution, RNA polymerase, antibiotic, DNA, 
substrates. Activity is plotted in Vo of the activity with- 
out antibiotics: (0) rifampicin; (0) RM41. 
effect on various stages of transcription. RNA 
polymerase is known to display a varying sensi- 
tivity to rifampicin at different stages of transcrip- 
tion. The greatest inhibiting effect is observed if 
rifampicin is added to a free RNA polymerase, 
while an RNA polymerase that has started RNA 
synthesis is rifampicin-resistant. After RNA poly- 
merase gets bound to DNA and forms open pro- 
moter complexes, rifampicin is much more slow to 
attack it than in the case of a free enzyme. There- 
fore when rifampicin and substrates are simultane- 
ously added to open complexes, the majority of the 
RNA polymerase molecules manage to start RNA 
synthesis and avoid the inhibiting effect [8]. The 
same effect is observed in the case of RM41 and 
rifampicin-resistant RNA polymerase (fig. 3): 
when RM41 and substrates are added to an RNA 
polymerase-T2 DNA complex formed at 37°C 
the inhibition is far less pronounced than with 
RM41 added to a free RNA polymerase. The 
number of rifampicin-resistant open complexes is 
known to diminish considerably with a fall in tem- 
perature and an increase in ionic strength. Fig. 4 
shows that the same dependences are observed with 
regard to the action of RM41 on the resistant RNA 
polymerase. 
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Fig. 3. Protection of RNA polymerase from RM41 after 
the formation of an open complex with DNA. (0) RNA 
polymerase and DNA were incubated in the buffer solu- 
tion for 7 min at 37°C to form open complexes, then the 
antibiotic (to lOOpg/ml) and substrates were added 
simultaneously, and the samples were incubated for 
another 10 min. (0) The antibiotic was added to RNA 
polymerase in the buffer solution, then the other compo- 
nents were added and the samples were incubated for 
10 min at 37°C. Activity is plotted in Vo of the enzyme 
activity without the antibiotic. 
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Fig. 4. Influence of temperature and ionic strength on 
the resistance of DNA-RNA polymerase complexes to 
RM41. (A) RNA polymerase and DNA were incubated 
in the buffer solution for 7 min at the temperature 
shown, then RM41 (to lOOpg/ml) and substrates were 
added simultaneously and the samples were transferred 
to 37°C for 10 min. RNA polymerase activity is plotted 
in % of the activity without the antibiotic. (B) RNA 
polymerase and DNA were incubated in the buffer solu- 
tion with NaCl in the concentration shown for 7 min at 
37°C. Then RM41 and substrates were added simultane- 
ously, and the samples were incubated for 10 min at 
37°C. Activity is plotted in qo of the activity without the 
antibiotic at 0.1 M NaCl. 
A study of the RNA polymerase-DNA binding 
using nitrocellulose filters has shown that RM41 in 
inhibiting concentrations (100 pg/ml) does not 
affect the enzyme’s binding to DNA (not shown). 
Thus all our results indicate that RM4, unlike de- 
rivatives of the AF/013 type, acts on a resistant 
RNA polymerase by a mechanism similar to the 
action of rifampicin upon a sensitive RNA poly- 
merase, possibly through interaction with the same 
enzyme centre. Therefore RM41 may prove useful 
for studies of the structure and functioning of that 
centre. 
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